about
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody produ...
Read More
9.33
1.06
(12.82%)
948.0K
XNAS Volume
XNAS 09 Jul, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Xencor Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..